Table of Contents
Journal of Hormones
Volume 2013 (2013), Article ID 386306, 4 pages
http://dx.doi.org/10.1155/2013/386306
Research Article

The Effects of Acute Arginine Vasopressin Administration on Social Cognition in Healthy Males

Brain & Mind Research Institute, The University of Sydney, Sydney, NSW 2050, Australia

Received 25 March 2013; Revised 26 April 2013; Accepted 13 May 2013

Academic Editor: Elisabetta Baldi

Copyright © 2013 Amanda R. Kenyon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Meyer-Lindenberg, G. Domes, P. Kirsch, and M. Heinrichs, “Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine,” Nature Reviews Neuroscience, vol. 12, no. 9, pp. 524–538, 2011. View at Google Scholar
  2. M. Ludwig and G. Leng, “Dendritic peptide release and peptide-dependent behaviours,” Nature Reviews Neuroscience, vol. 7, no. 2, pp. 126–136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Gimpl and F. Fahrenholz, “The oxytocin receptor system: structure, function, and regulation,” Physiological Reviews, vol. 81, no. 2, pp. 629–683, 2001. View at Google Scholar · View at Scopus
  4. I. F. Bielsky, S. B. Hu, K. L. Szegda, H. Westphal, and L. J. Young, “Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice,” Neuropsychopharmacology, vol. 29, no. 3, pp. 483–493, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. J. N. Ferguson, J. M. Aldag, T. R. Insel, and L. J. Young, “Oxytocin in the medial amygdala is essential for social recognition in the mouse,” Journal of Neuroscience, vol. 21, no. 20, pp. 8278–8285, 2001. View at Google Scholar · View at Scopus
  6. J. T. Winslow, N. Hastings, C. S. Carter, C. R. Harbaugh, and T. R. Insel, “A role for central vasopressin in pair bonding in monogamous prairie voles,” Nature, vol. 365, no. 6446, pp. 545–548, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Guastella, A. R. Kenyon, G. A. Alvares, D. S. Carson, and I. B. Hickie, “Intranasal arginine vasopressin enhances the encoding of happy and angry faces in humans,” Biological Psychiatry, vol. 67, no. 12, pp. 1220–1222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Guastella, A. R. Kenyon, C. Unkelbach, G. A. Alvares, and I. B. Hickie, “Arginine Vasopressin selectively enhances recognition of sexual cues in male humans,” Psychoneuroendocrinology, vol. 36, no. 2, pp. 294–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Thompson, S. Gupta, K. Miller, S. Mills, and S. Orr, “The effects of vasopressin on human facial responses related to social communication,” Psychoneuroendocrinology, vol. 29, no. 1, pp. 35–48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. R. Thompson, K. George, J. C. Walton, S. P. Orr, and J. Benson, “Sex-specific influences of vasopressin on human social communication,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 20, pp. 7889–7894, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. F. Zink, L. Kempf, S. Hakimi, C. A. Rainey, J. L. Stein, and A. Meyer-Lindenberg, “Vasopressin modulates social recognition-related activity in the left temporoparietal junction in humans,” Translational Psychiatry, vol. 1, article e3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. F. Zink, J. L. Stein, L. Kempf, S. Hakimi, and A. Meyer-Lindenberg, “Vasopressin modulates medial prefrontal cortex-amygdala circuitry during emotion processing in humans,” Journal of Neuroscience, vol. 30, no. 20, pp. 7017–7022, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Domes, M. Heinrichs, A. Michel, C. Berger, and S. C. Herpertz, “Oxytocin improves “mind-reading” in humans,” Biological Psychiatry, vol. 61, pp. 731–733, 2007. View at Google Scholar
  14. S. Baron-Cohen, S. Wheelwright, J. Hill, Y. Raste, and I. Plumb, “The “reading the mind in the eyes” test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism,” Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 42, no. 2, pp. 241–251, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. Guastella, S. L. Einfeld, K. M. Gray et al., “Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders,” Biological Psychiatry, vol. 67, no. 7, pp. 692–694, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Manning, A. Misicka, A. Olma et al., “Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics,” Journal of Neuroendocrinology, vol. 24, no. 4, pp. 609–628, 2012. View at Google Scholar
  17. F. Uzefovsky, I. Shalev, S. Israel, A. Knafo, and R. P. Ebstein, “Vasopressin selectively impairs emotion recognition in men,” Psychoneuroendocrinology, vol. 37, pp. 576–580, 2012. View at Google Scholar
  18. M. R. Leary, “A brief version of the fear of negative evaluation scale,” Personality and Social Psychology Bulletin, vol. 9, no. 3, pp. 371–375, 1983. View at Google Scholar
  19. P. F. Lovibond and S. H. Lovibond, “The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the Beck Depression and Anxiety Inventories,” Behaviour Research and Therapy, vol. 33, no. 3, pp. 335–343, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. D. M. Mcnair, M. Lorr, and L. F. Droppelman, Manual for the Profile of Mood States, Educational and Industrial Testing Service, San Diego, Calif, USA, 1971.
  21. S. Shahrestani, A. H. Kemp, and A. J. Guastella, “The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: a meta-analysis,” Neuropsychopharmacology, 2013. View at Publisher · View at Google Scholar
  22. G. J. de Vries, “Sex differences in vasopressin and oxytocin innervation of the brain,” Progress in Brain Research, vol. 170, pp. 17–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Choleris, A. E. Clipperton-Allen, A. Phan, and M. Kavaliers, “Neuroendocrinology of social information processing in rats and mice,” Frontiers in Neuroendocrinology, vol. 30, no. 4, pp. 442–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. E. Taylor, S. Saphire-Bernstein, and T. E. Seeman, “Are plasma oxytocin in women and plasma vasopressin in men biomarkers of distressed pair-bond relationships?” Psychological Science, vol. 21, no. 1, pp. 3–7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Walum, L. Westberg, S. Henningsson et al., “Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 37, pp. 14153–14156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Yeargin-Allsopp, C. Rice, T. Karapurkar, N. Doernberg, C. Boyle, and C. Murphy, “Prevalence of autism in a US metropolitan area,” Journal of the American Medical Association, vol. 289, no. 1, pp. 49–55, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. J. A. Bartz, J. Zaki, N. Bolger, and K. N. Ochsner, “Social effects of oxytocin in humans: context and person matter,” Trends in Cognitive Sciences, vol. 15, no. 7, pp. 301–309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. D. Marshall, “Posttraumatic stress disorder and partner-specific social cognition: a pilot study of sex differences in the impact of arginine vasopressin,” Biological Psychology, vol. 93, no. 2, pp. 296–303, 2013. View at Google Scholar
  29. L. J. Young and Z. Wang, “The neurobiology of pair bonding,” Nature Neuroscience, vol. 7, no. 10, pp. 1048–1054, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Guastella, G. A. Alvares, I. B. Hickie, H. K. Chan, T. F. Chen, and R. B. Banati, “Unitary hormonal models, peripheral markers, and evaluation of response to drug: a response to Weisman and Feldman,” Psychoneuroendocrinology, vol. 38, no. 5, pp. 627–628, 2013. View at Google Scholar